• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

ENZ [ Enzo Biochem Inc ]
Last Trade 2.91 Date 6/19/2021
Change % 0.35 % Price Change 0.01
Open 2.85 52 Week High 4.85
High 2.925 52 Week Low 1.8
Low 2.81 Type stock
Volume 610083 Average Volume 364081
Prev Close 2.9 Stock Exchange NYSE
Bid 2.83 Ask 2.93
Bid Size 3 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 1.3403 Book Value Yield 0.4606
Buy Back Yield CAPE Ratio
Cash Return -0.0723 Cash Flow per Share -0.0994
Cash Flow Yield -0.0342 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0103 EV/EBIT 25.796
EV/EBITDA 16.841 EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income 98.2745
EV / Revenue 1.1204 EV / Total Asset 1.1088
Expected Dividend Growth Rate Free Cash Flow per Share -0.1893
Free Caash Flow Ratio Free Cash Flow Yield -0.065
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio 27.643991 Payout Ratio 0.0
PB Ratio 2.171146 PB Ratio 10 Year Growth 0.03236
PB Ratio 3 Year Growth 2.02222 Cash Ratio 3 Year Average 277.1848
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio 97.0
PE Ratio 10 Year Average 41.347064 PE Ratio 10 Year Growth
PE Ratio 10 Year High 142.5 PE Ratio 10 Year Low 5.226804
PE Ratio 1 Year Avg 99.722222 PE Ratio 1 Year High 102.666667
PE Ratio 1 Year Low 96.666667 PE Ratio 3 Year Avg 86.436175
PE Ratio 5 Year Avg 45.34131 PE Ratio 5 Year High 142.5
PE Ratio 5 Year Low 5.226804 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 65.592541 Price Change 1 Month 0.944805
Price to Cash Ratio 3.133046 Price / EBITDA 18.708546
Price to Sales Ratio 1.244685 Price to Sales Ratio 10 Year Growth -0.013923
Price to Sales Ratio 3 Year Avg 1.638362 Price to Sales Ratio 5 Year Avg 45.34131
Sale per Share 2.3379 Sales Yield 0.8034
Sustainable Growth Rate 0.0201 Tangible Book Value per Share 1.1801
Tangible Book Value per Share 3 year Avg 1.3166 Tangible Book Value per Share 5 year Avg 1.46
Total Asset per Share 2.3441 Total Yield
Working Capital per Share 0.8691 Working Capital per Share 3 Year Avg 1.0408
Working Capital per Share 5 Year Avg 1.2299 Beta 0.949429
Company Profile

Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. The Enzo Life Sciences segment manufactures, develops, and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers. It offers products applied in the fields of antibiotics, autophagy, cancer, cell cycle, cell death, cell signaling, cell trafficking, genomics/molecular biology, immunology, inflammation, lipid signaling, neurobiology, protein degradation, ROS/RNS, and stress/heat shock. The Enzo Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It also operates a full-service clinical laboratory, a network of 30 patient service centers, a stand alone or rapid response laboratory, and a full-service phlebotomy department. The Enzo Therapeutics segment engages in the research and development of various therapeutic drug candidates based on cell signaling, immune regulation, and gene regulation for the treatment of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem, Inc. sells its products through direct sales force and distributors in the United States, Switzerland, the United Kingdom, Belgium, and Germany. The company was founded in 1976 and is headquartered in New York, New York.